메뉴 건너뛰기




Volumn 12, Issue 1, 2003, Pages 5-13

Effect of doxazosin GITS on blood pressure in hypertensive and normotensive patients: A review of hypertension and BPH studies

Author keywords

Benign prostatic hyperplasia (BPH); Blood pressure; Doxazosin; Hypertension

Indexed keywords

DOXAZOSIN; ANTIHYPERTENSIVE AGENT;

EID: 0038320266     PISSN: 08038023     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (14)

References (40)
  • 1
    • 0022993007 scopus 로고
    • Acute and chronic haemodynamic effects of doxazosin in hypertension at rest and during exercise
    • Lund-Johansen P, Omvik P, Haugland H. Acute and chronic haemodynamic effects of doxazosin in hypertension at rest and during exercise. Br J Clin Pharmacol 1986; 21 Suppl 1: 45-54S.
    • (1986) Br J Clin Pharmacol , vol.21 , Issue.SUPPL. 1
    • Lund-Johansen, P.1    Omvik, P.2    Haugland, H.3
  • 2
    • 9344253821 scopus 로고    scopus 로고
    • Long-term effects on plasma lipids of diet and drugs to treat hypertension
    • Treatment of Mild Hypertension Study (TOMHS) Research Group
    • Grimm RJ, Flack J, Grandits G, et al. Long-term effects on plasma lipids of diet and drugs to treat hypertension. Treatment of Mild Hypertension Study (TOMHS) Research Group. JAMA 1996; 275: 1549-56.
    • (1996) JAMA , vol.275 , pp. 1549-1556
    • Grimm, R.J.1    Flack, J.2    Grandits, G.3
  • 3
    • 0030810407 scopus 로고    scopus 로고
    • Effect of doxazosin therapy on glucose tolerance and lipid metabolism in hypertensive patients with impaired glucose tolerance
    • Shionoiri H, Ashino K, Yamanaka K, Shindo K, Hiroto S, Arita T. Effect of doxazosin therapy on glucose tolerance and lipid metabolism in hypertensive patients with impaired glucose tolerance. Clin Ther 1997; 19: 527-36.
    • (1997) Clin Ther , vol.19 , pp. 527-536
    • Shionoiri, H.1    Ashino, K.2    Yamanaka, K.3    Shindo, K.4    Hiroto, S.5    Arita, T.6
  • 4
    • 0027326310 scopus 로고
    • Treatment of Mild Hypertension Study. Final results
    • Treatment of Mild Hypertension Study Research Group
    • Neaton JD, Grimm RH, Jr, Prineas RJ, et al. Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group. JAMA 1993; 270: 713-24.
    • (1993) JAMA , vol.270 , pp. 713-724
    • Neaton, J.D.1    Grimm R.H., Jr.2    Prineas, R.J.3
  • 5
    • 0026078055 scopus 로고
    • Doxazosin and atenolol as monotherapy in mild and moderate hypertension: A randomized, parallel study with a three-year follow-up
    • Talseth T, Westlie L, Daae L. Doxazosin and atenolol as monotherapy in mild and moderate hypertension: a randomized, parallel study with a three-year follow-up. Am Heart J 1991; 121 (1 Pt 2): 280-5.
    • (1991) Am Heart J , vol.121 , Issue.1 PART 2 , pp. 280-285
    • Talseth, T.1    Westlie, L.2    Daae, L.3
  • 6
    • 0026034158 scopus 로고
    • Double-blind comparison of doxazosin and enalapril in patients with mild or moderate essential hypertension
    • Wessels F. Double-blind comparison of doxazosin and enalapril in patients with mild or moderate essential hypertension. Am Heart J 1991; 121 (1 Pt 2): 299-303.
    • (1991) Am Heart J , vol.121 , Issue.1 PART 2 , pp. 299-303
    • Wessels, F.1
  • 7
    • 0034126205 scopus 로고    scopus 로고
    • The addition of doxazosin to the therapeutic regimen of hypertensive patients inadequately controlled with other antihypertensive medications: A randomized, placebo-controlled study
    • Black HR, Sollins JS, Garofalo JL. The addition of doxazosin to the therapeutic regimen of hypertensive patients inadequately controlled with other antihypertensive medications: a randomized, placebo-controlled study. Am J Hypertens 2000; 13 (5 Pt 1): 468-74.
    • (2000) Am J Hypertens , vol.13 , Issue.5 PART 1 , pp. 468-474
    • Black, H.R.1    Sollins, J.S.2    Garofalo, J.L.3
  • 8
    • 0033863189 scopus 로고    scopus 로고
    • Clinically additive effect between doxazosin and amlodipine in the treatment of essential hypertension
    • Nalbantgil S, Nalbantgil I, Onder R. Clinically additive effect between doxazosin and amlodipine in the treatment of essential hypertension. Am J Hypertens 2000; 13: 921-26.
    • (2000) Am J Hypertens , vol.13 , pp. 921-926
    • Nalbantgil, S.1    Nalbantgil, I.2    Onder, R.3
  • 9
    • 0024230216 scopus 로고
    • A single-blind study of doxazosin in the treatment of essential hypertension when added to nonresponders to angiotensin-converting enzyme inhibitor therapy
    • Englert RG, Mauersberger H. A single-blind study of doxazosin in the treatment of essential hypertension when added to nonresponders to angiotensin-converting enzyme inhibitor therapy. Am Heart J 1988; 116 (6 Pt 2): 1826-32.
    • (1988) Am Heart J , vol.116 , Issue.6 PART 2 , pp. 1826-1832
    • Englert, R.G.1    Mauersberger, H.2
  • 10
    • 0024204177 scopus 로고
    • The addition of doxazosin to the treatment regimen of hypertensive patients not responsive to nifedipine
    • Lindner UK, von Manteuffel GE, Stafunsky M. The addition of doxazosin to the treatment regimen of hypertensive patients not responsive to nifedipine. Am Heart J 1988; 116 (6 Pt 2): 1814-20.
    • (1988) Am Heart J , vol.116 , Issue.6 PART 2 , pp. 1814-1820
    • Lindner, U.K.1    Von Manteuffel, G.E.2    Stafunsky, M.3
  • 11
    • 0025145047 scopus 로고
    • Doxazosin in combination with atenolol in essential hypertension: A double-blind placebo-controlled multicentre trial
    • Searle M, Dathan R, Dean S, Christensen CC, Westheim A. Doxazosin in combination with atenolol in essential hypertension: a double-blind placebo-controlled multicentre trial. Eur J Clin Pharmacol 1990; 39: 299-300.
    • (1990) Eur J Clin Pharmacol , vol.39 , pp. 299-300
    • Searle, M.1    Dathan, R.2    Dean, S.3    Christensen, C.C.4    Westheim, A.5
  • 12
    • 0031884478 scopus 로고    scopus 로고
    • Effect of antihypertensive treatment with doxazosin on insulin sensitivity and fibrinolytic parameters
    • Zehetgruber M, Christ G, Gabriel H, et al. Effect of antihypertensive treatment with doxazosin on insulin sensitivity and fibrinolytic parameters. Thromb Haemost 1998; 79: 378-82.
    • (1998) Thromb Haemost , vol.79 , pp. 378-382
    • Zehetgruber, M.1    Christ, G.2    Gabriel, H.3
  • 13
    • 0029030429 scopus 로고
    • Alpha 1-blocker doxazosin improves peripheral insulin sensitivity in diabetic hypertensive patients
    • Giorda C, Appendino M, Mason MG, Imperiale E, Pagano G. Alpha 1-blocker doxazosin improves peripheral insulin sensitivity in diabetic hypertensive patients. Metabolism 1995; 44: 673-6.
    • (1995) Metabolism , vol.44 , pp. 673-676
    • Giorda, C.1    Appendino, M.2    Mason, M.G.3    Imperiale, E.4    Pagano, G.5
  • 14
    • 0030022644 scopus 로고    scopus 로고
    • Antihypertensive and metabolic effects of doxazosin in hypertensive patients with concomitant non-insulin-dependent diabetes mellitus
    • Inoue Y, Kaku K, Kaneko T, et al. Antihypertensive and metabolic effects of doxazosin in hypertensive patients with concomitant non-insulin-dependent diabetes mellitus. J Int Med Res 1996; 24: 138-46.
    • (1996) J Int Med Res , vol.24 , pp. 138-146
    • Inoue, Y.1    Kaku, K.2    Kaneko, T.3
  • 15
    • 0029022190 scopus 로고
    • Doxazosin lowers blood pressure and improves insulin responses to a glucose load with no changes in tyrosine kinase activity of insulin binding
    • Dominguez LJ, Weinberger MH, Cefalu WT, et al. Doxazosin lowers blood pressure and improves insulin responses to a glucose load with no changes in tyrosine kinase activity of insulin binding. Am J Hypertens 1995; 8 (5 Pt 1): 528-32.
    • (1995) Am J Hypertens , vol.8 , Issue.5 PART 1 , pp. 528-532
    • Dominguez, L.J.1    Weinberger, M.H.2    Cefalu, W.T.3
  • 16
    • 0028331994 scopus 로고
    • Changes in glucose, insulin, lipid, lipoprotein, and apoprotein concentrations and insulin action in doxazosin-treated patients with hypertension
    • Maheux P, Facchini F, Jeppesen J, et al. Changes in glucose, insulin, lipid, lipoprotein, and apoprotein concentrations and insulin action in doxazosin-treated patients with hypertension. Am J Hypertens 1994; 7: 416-24.
    • (1994) Am J Hypertens , vol.7 , pp. 416-424
    • Maheux, P.1    Facchini, F.2    Jeppesen, J.3
  • 17
    • 0027449082 scopus 로고
    • Effects of doxazosin, a selective alpha 1-inhibitor, on plasma insulin and blood glucose response to a glucose tolerance test in essential hypertension
    • Giorda C, Appendino M. Effects of doxazosin, a selective alpha 1-inhibitor, on plasma insulin and blood glucose response to a glucose tolerance test in essential hypertension. Metabolism 1993; 42: 1440-2.
    • (1993) Metabolism , vol.42 , pp. 1440-1442
    • Giorda, C.1    Appendino, M.2
  • 18
    • 0026445233 scopus 로고
    • Glucose, insulin, and lipid metabolism in doxazosin-treated patients with hypertension
    • Shieh SM, Sheu WH, Shen DC, Fuh MM, Chen YD, Reaven GM. Glucose, insulin, and lipid metabolism in doxazosin-treated patients with hypertension. Am J Hypertens 1992; 5: 827-31.
    • (1992) Am J Hypertens , vol.5 , pp. 827-831
    • Shieh, S.M.1    Sheu, W.H.2    Shen, D.C.3    Fuh, M.M.4    Chen, Y.D.5    Reaven, G.M.6
  • 19
    • 0031666899 scopus 로고    scopus 로고
    • Effect of doxazosin in mild to moderate hypertensive patients with insulin-dependent diabetes mellitus
    • Calo L, Davis PA, Cantaro S, et al. Effect of doxazosin in mild to moderate hypertensive patients with insulin-dependent diabetes mellitus. Acta Diabetol 1998; 35: 96-100.
    • (1998) Acta Diabetol , vol.35 , pp. 96-100
    • Calo, L.1    Davis, P.A.2    Cantaro, S.3
  • 20
    • 0034828280 scopus 로고    scopus 로고
    • Doxazosin reduces prevalence of small dense low density lipoprotein and remnant-like particle cholesterol levels in nondiabetic and diabetic hypertensive patients
    • Hirano T, Yoshino G, Kashiwazaki K, Adachi M. Doxazosin reduces prevalence of small dense low density lipoprotein and remnant-like particle cholesterol levels in nondiabetic and diabetic hypertensive patients. Am J Hypertens 2001; 14 (9 Pt 1): 908-13.
    • (2001) Am J Hypertens , vol.14 , Issue.9 PART 1 , pp. 908-913
    • Hirano, T.1    Yoshino, G.2    Kashiwazaki, K.3    Adachi, M.4
  • 21
    • 0026583879 scopus 로고
    • Reduction of left ventricular hypertrophy after longterm antihypertensive treatment with doxazosin
    • Agabiti-Rosei E, Muiesan ML, Rizzoni D, et al. Reduction of left ventricular hypertrophy after longterm antihypertensive treatment with doxazosin. J Hum Hypertens 1992; 6: 9-15.
    • (1992) J Hum Hypertens , vol.6 , pp. 9-15
    • Agabiti-Rosei, E.1    Muiesan, M.L.2    Rizzoni, D.3
  • 22
    • 0026089395 scopus 로고
    • Echocardiographic assessment of doxazosin on left ventricular mass in patients with essential hypertension
    • Monsalve P, Vera O, Perez Acuna F, et al. Echocardiographic assessment of doxazosin on left ventricular mass in patients with essential hypertension. Am Heart J 1991; 121 (1 Pt 2): 356-61.
    • (1991) Am Heart J , vol.121 , Issue.1 PART 2 , pp. 356-361
    • Monsalve, P.1    Vera, O.2    Perez Acuna, F.3
  • 23
    • 0026059669 scopus 로고
    • Doxazosin in the treatment of mild or moderate essential hypertension: An echocardiographic study
    • Corral JL, Lopez NC, Pecorelli A, Rincon LA, Teran VD. Doxazosin in the treatment of mild or moderate essential hypertension: an echocardiographic study. Am Heart J 1991; 121 (1 Pt 2): 352-6.
    • (1991) Am Heart J , vol.121 , Issue.1 PART 2 , pp. 352-356
    • Corral, J.L.1    Lopez, N.C.2    Pecorelli, A.3    Rincon, L.A.4    Teran, V.D.5
  • 24
    • 0027502569 scopus 로고
    • Doxazosin treatment in patients with prostatic obstruction. A double-blind placebo-controlled study
    • Christensen MM, Bendix Holme J, Rasmussen PC, et al. Doxazosin treatment in patients with prostatic obstruction. A double-blind placebo-controlled study. Scand J Urol Nephrol 1993; 27: 39-44.
    • (1993) Scand J Urol Nephrol , vol.27 , pp. 39-44
    • Christensen, M.M.1    Bendix Holme, J.2    Rasmussen, P.C.3
  • 25
    • 0028285327 scopus 로고
    • A three month double-blind study of doxazosin as treatment for benign prostatic bladder outlet obstruction
    • Chapple CR, Carter P, Christmas TJ, et al. A three month double-blind study of doxazosin as treatment for benign prostatic bladder outlet obstruction. Br J Urol 1994; 74: 50-6.
    • (1994) Br J Urol , vol.74 , pp. 50-56
    • Chapple, C.R.1    Carter, P.2    Christmas, T.J.3
  • 26
    • 0031930664 scopus 로고    scopus 로고
    • Effects of doxazosin in patients with mild, intermediate, and severe benign prostatic hyperplasia
    • Mobley DF, Dias N, Levenstein M. Effects of doxazosin in patients with mild, intermediate, and severe benign prostatic hyperplasia. Clin Ther 1998; 20: 101-9.
    • (1998) Clin Ther , vol.20 , pp. 101-109
    • Mobley, D.F.1    Dias, N.2    Levenstein, M.3
  • 27
    • 0031021415 scopus 로고    scopus 로고
    • Doxazosin for benign prostatic hyperplasia: Long-term efficacy and safety in hypertensive and normotensive patients
    • Lepor H, Kaplan S, Klimberg I, et al. Doxazosin for benign prostatic hyperplasia: long-term efficacy and safety in hypertensive and normotensive patients. J Urol 1997; 157: 525-30.
    • (1997) J Urol , vol.157 , pp. 525-530
    • Lepor, H.1    Kaplan, S.2    Klimberg, I.3
  • 28
    • 0029002126 scopus 로고
    • Doxazosin in the treatment of benign prostatic hyperplasia in normotensive patients: A multicenter study
    • Fawzy A, Braun K, Lewis GP, Gaffney M, Ice K, Dias N. Doxazosin in the treatment of benign prostatic hyperplasia in normotensive patients: a multicenter study. J Urol 1995; 154: 105-9.
    • (1995) J Urol , vol.154 , pp. 105-109
    • Fawzy, A.1    Braun, K.2    Lewis, G.P.3    Gaffney, M.4    Ice, K.5    Dias, N.6
  • 29
    • 0029024313 scopus 로고
    • Doxazosin for the treatment of benign prostatic hyperplasia in patients with mild to moderate essential hypertension: A double-blind, placebo-controlled, dose-response multicenter study
    • Gillenwater JY, Conn RL, Chrysant SG, et al. Doxazosin for the treatment of benign prostatic hyperplasia in patients with mild to moderate essential hypertension: a double-blind, placebo-controlled, dose-response multicenter study. J Urol 1995; 154: 110-15.
    • (1995) J Urol , vol.154 , pp. 110-115
    • Gillenwater, J.Y.1    Conn, R.L.2    Chrysant, S.G.3
  • 30
    • 0028869716 scopus 로고
    • Doxazosin. An update of its clinical pharmacology and therapeutic applications in hypertension and benign prostatic hyperplasia
    • Fulton B, Wagstaff A, Sorkin E. Doxazosin. An update of its clinical pharmacology and therapeutic applications in hypertension and benign prostatic hyperplasia. Drugs 1995;49:295-320.
    • (1995) Drugs , vol.49 , pp. 295-320
    • Fulton, B.1    Wagstaff, A.2    Sorkin, E.3
  • 31
    • 0032749958 scopus 로고    scopus 로고
    • Clinical pharmacokinetics of doxazosin in a controlled-release gastrointestinal therapeutic system (GITS) formulation
    • Chung M, Vashi V, Puente J, Sweeney M, Meredith P. Clinical pharmacokinetics of doxazosin in a controlled-release gastrointestinal therapeutic system (GITS) formulation. Br J Clin Pharmacol 1999; 48: 678-87.
    • (1999) Br J Clin Pharmacol , vol.48 , pp. 678-687
    • Chung, M.1    Vashi, V.2    Puente, J.3    Sweeney, M.4    Meredith, P.5
  • 32
    • 0032890927 scopus 로고    scopus 로고
    • Effects of doxazosin in the gastrointestinal therapeutic system formulation versus doxazosin standard and placebo in mild-to-moderate hypertension
    • Doxazosin Investigators' Study Group
    • Os I, Stokke HP. Effects of doxazosin in the gastrointestinal therapeutic system formulation versus doxazosin standard and placebo in mild-to-moderate hypertension. Doxazosin Investigators' Study Group. J Cardiovasc Pharmacol 1999; 33: 791-7.
    • (1999) J Cardiovasc Pharmacol , vol.33 , pp. 791-797
    • Os, I.1    Stokke, H.P.2
  • 33
    • 0032728650 scopus 로고    scopus 로고
    • Doxazosin GITS compared with doxazosin standard and placebo in patients with mild hypertension
    • Os I, Stokke HP. Doxazosin GITS compared with doxazosin standard and placebo in patients with mild hypertension. Blood Press 1999; 8: 184-91.
    • (1999) Blood Press , vol.8 , pp. 184-191
    • Os, I.1    Stokke, H.P.2
  • 34
    • 0033755524 scopus 로고    scopus 로고
    • Double-blind trial of the efficacy and tolerability of doxazosin in the gastrointestinal therapeutic system, doxazosin standard, and placebo in patients with benign prostatic hyperplasia
    • Andersen M, Dahlstrand C, Hoye K. Double-blind trial of the efficacy and tolerability of doxazosin in the gastrointestinal therapeutic system, doxazosin standard, and placebo in patients with benign prostatic hyperplasia. Eur Urol 2000; 38: 400-9.
    • (2000) Eur Urol , vol.38 , pp. 400-409
    • Andersen, M.1    Dahlstrand, C.2    Hoye, K.3
  • 35
    • 12544258110 scopus 로고    scopus 로고
    • Doxazosin GITS and doxazosin standard in patients with benign prostatic hyperplasia: Double blind trial of efficacy and tolerability
    • November
    • Gratzke P, Kirby R. Doxazosin GITS and doxazosin standard in patients with benign prostatic hyperplasia: double blind trial of efficacy and tolerability. Fortschr Med 2000 November: 83-93.
    • (2000) Fortschr Med , pp. 83-93
    • Gratzke, P.1    Kirby, R.2
  • 36
    • 0035122753 scopus 로고    scopus 로고
    • A combined analysis of double-blind trials of the efficacy and tolerability of doxazosin-gastrointestinal therapeutic system, doxazosin standard and placebo in patients with benign prostatic hyperplasia
    • Kirby RS, Andersen M, Gratzke P, Dahlstrand C, Hoye K. A combined analysis of double-blind trials of the efficacy and tolerability of doxazosin-gastrointestinal therapeutic system, doxazosin standard and placebo in patients with benign prostatic hyperplasia. BJU Int 2001; 87: 192-200.
    • (2001) BJU Int , vol.87 , pp. 192-200
    • Kirby, R.S.1    Andersen, M.2    Gratzke, P.3    Dahlstrand, C.4    Hoye, K.5
  • 37
    • 0035522330 scopus 로고    scopus 로고
    • Impact of high-normal blood pressure on the risk of cardiovascular disease
    • Vasan RS, Larson MG, Leip EP, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001; 345: 1291-7.
    • (2001) N Engl J Med , vol.345 , pp. 1291-1297
    • Vasan, R.S.1    Larson, M.G.2    Leip, E.P.3
  • 38
    • 0029554501 scopus 로고
    • Doxazosin in physiologically and pharmacologically normotensive men with benign prostatic hyperplasia
    • Kaplan SA, Meade-D'Alisera P, Quinones S, Soldo KA. Doxazosin in physiologically and pharmacologically normotensive men with benign prostatic hyperplasia. Urology 1995; 46: 512-17.
    • (1995) Urology , vol.46 , pp. 512-517
    • Kaplan, S.A.1    Meade-D'Alisera, P.2    Quinones, S.3    Soldo, K.A.4
  • 39
    • 0028129565 scopus 로고
    • Doxazosin and 48-hour ambulatory blood pressure monitoring in normotensive subjects
    • Takata Y, Yoshizumi T, Ito Y, Hirota Y, Fujishima M. Doxazosin and 48-hour ambulatory blood pressure monitoring in normotensive subjects. Jpn Circ J 1994; 58: 403-8.
    • (1994) Jpn Circ J , vol.58 , pp. 403-408
    • Takata, Y.1    Yoshizumi, T.2    Ito, Y.3    Hirota, Y.4    Fujishima, M.5
  • 40
    • 0034685403 scopus 로고    scopus 로고
    • Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
    • ALLHAT Collaborative Research Group
    • Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group. JAMA 2000; 283: 1967-75.
    • (2000) JAMA , vol.283 , pp. 1967-1975


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.